D-0503-2024 Class II Terminated

Recalled by American Regent, Inc. — New Albany, OH

FDA drug recall D-0503-2024 was initiated by American Regent, Inc. on May 14, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility. The recall status is terminated (terminated Dec 23, 2025). Affected quantity: 4,136 cartons (10 vials in each carton).

Recall details

Product Type
Drugs
Report Date
May 29, 2024
Initiation Date
May 14, 2024
Termination Date
Dec 23, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,136 cartons (10 vials in each carton)

Product description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10

Reason for recall

Lack of Assurance of Sterility.

Distribution pattern

UT only

Code information

Lot #: 23087N0C0, Exp. Date 11/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0503-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0503-2024. Report a data issue: hello@regdatalab.com.